These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 18388053)
1. The effects of different beta-blockers on left-ventricular volume and function after primary coronary stenting in acute myocardial infarction. Lee SH; Yoon SB; Cho JR; Choi S; Jung JH; Lee N Angiology; 2008 Dec-2009 Jan; 59(6):676-81. PubMed ID: 18388053 [TBL] [Abstract][Full Text] [Related]
2. Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment. Paraskevaidis I; Farmakis D; Parissis JT; Dodouras T; Filippatos G; Tsiapras D; Kremastinos DT J Card Fail; 2007 Mar; 13(2):108-13. PubMed ID: 17395050 [TBL] [Abstract][Full Text] [Related]
3. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy. Quaife RA; Gilbert EM; Christian PE; Datz FL; Mealey PC; Volkman K; Olsen SL; Bristow MR Am J Cardiol; 1996 Oct; 78(7):779-84. PubMed ID: 8857482 [TBL] [Abstract][Full Text] [Related]
4. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy. Doughty RN; Whalley GA; Walsh HA; Gamble GD; López-Sendón J; Sharpe N; Circulation; 2004 Jan; 109(2):201-6. PubMed ID: 14707020 [TBL] [Abstract][Full Text] [Related]
5. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC). Bergström A; Andersson B; Edner M; Nylander E; Persson H; Dahlström U Eur J Heart Fail; 2004 Jun; 6(4):453-61. PubMed ID: 15182771 [TBL] [Abstract][Full Text] [Related]
6. An echocardiographic analysis of the long-term effects of carvedilol on left ventricular remodeling, systolic performance, and ventricular filling patterns in dilated cardiomyopathy. Rahko PS Echocardiography; 2005 Aug; 22(7):547-54. PubMed ID: 16060890 [TBL] [Abstract][Full Text] [Related]
7. The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials? Otterstad JE; Ford I Eur J Heart Fail; 2002 Aug; 4(4):501-6. PubMed ID: 12167391 [TBL] [Abstract][Full Text] [Related]
8. Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction. Wei S; Chow LT; Sanderson JE J Am Coll Cardiol; 2000 Jul; 36(1):276-81. PubMed ID: 10898446 [TBL] [Abstract][Full Text] [Related]
9. A comparison of the two beta-blockers carvedilol and atenolol on left ventricular ejection fraction and clinical endpoints after myocardial infarction. a single-centre, randomized study of 232 patients. Jonsson G; Abdelnoor M; Müller C; Kjeldsen SE; Os I; Westheim A Cardiology; 2005; 103(3):148-55. PubMed ID: 15785019 [TBL] [Abstract][Full Text] [Related]
10. Effects of carvedilol on left ventricular regional wall motion in patients with heart failure caused by ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group. Doughty RN; Whalley GA; Gamble G; MacMahon S; Sharpe N J Card Fail; 2000 Mar; 6(1):11-8. PubMed ID: 10746814 [TBL] [Abstract][Full Text] [Related]
11. Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats. Yaoita H; Sakabe A; Maehara K; Maruyama Y Circulation; 2002 Feb; 105(8):975-80. PubMed ID: 11864928 [TBL] [Abstract][Full Text] [Related]
12. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure. Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms underlying improvements in ejection fraction with carvedilol in heart failure. Maurer MS; Sackner-Bernstein JD; El-Khoury Rumbarger L; Yushak M; King DL; Burkhoff D Circ Heart Fail; 2009 May; 2(3):189-96. PubMed ID: 19808339 [TBL] [Abstract][Full Text] [Related]
14. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure. Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314 [TBL] [Abstract][Full Text] [Related]
15. Carvedilol: use in chronic heart failure. Doughty RN; White HD Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454 [TBL] [Abstract][Full Text] [Related]
16. Effects of β-blockers on left ventricular remodeling in patients with preserved ejection fraction after acute myocardial infarction. Horiuchi Y; Tanimoto S; Aoki J; Nakajima H; Hara K; Tanabe K Int J Cardiol; 2016 Oct; 221():765-9. PubMed ID: 27428318 [TBL] [Abstract][Full Text] [Related]
17. Comparative effects of cilazapril, carvedilol and their combination in preventing from left ventricular remodelling after acute myocardial infarction in rats. Yang Y; Tang Y; Ruan Y; Li Y; Zhou Y; Gao R; Chen J; Chen Z J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):31-5. PubMed ID: 11984745 [TBL] [Abstract][Full Text] [Related]
18. Carvedilol versus metoprolol in the acute phase of myocardial infarction: Bonnemeier H; Ortak J; Tölg R; Witt M; Schmidt J; Wiegand UK; Bode F; Schunkert H; Richardt G Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S222-6. PubMed ID: 15683501 [TBL] [Abstract][Full Text] [Related]
19. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy. Tatli E; Kurum T Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561 [TBL] [Abstract][Full Text] [Related]
20. Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction. Foster RE; Johnson DB; Barilla F; Blackwell GG; Orr R; Roney M; Stanley AW; Pohost GM; Dell'Italia LJ Am Heart J; 1998 Aug; 136(2):269-75. PubMed ID: 9704689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]